i-Expand

If AI had a flavour, this week it would 𝘵𝘢𝘴𝘵𝘦 𝘭𝘪𝘬𝘦 𝘴𝘵𝘳𝘢𝘸𝘣𝘦𝘳𝘳𝘪𝘦𝘴 🍓. OpenAI ’s latest LLM model, o1 (known before as Strawberry) is giving #investors a sugar rush. The release happens at a time when OpenAI is raising money at a valuation of $150 billion. Pre-money. 👀 The market dislocation between AI #business fundamentals and expectations is increasing Do the business fundamentals justify such a valuation❓ Does it matter❓ Let's look at some commercial pointers. 🟣 𝐋𝐋𝐌 𝐌𝐎𝐃𝐄𝐋𝐒 𝐀𝐑𝐄 𝐂𝐎𝐌𝐌𝐎𝐃𝐈𝐓𝐈𝐒𝐈𝐍𝐆 Last month, Meta dropped a bomb on the GenAI industry by offering more than OpenAI does and for free. Meta is making its flagship model, Llama 3.1. 405B, available to anyone who wants it. This version can do pretty much anything that OpenAI, Gemini, or Anthropic are capable of, and just as well (reportedly). Moreover, companies may do so at a fraction of the cost because of its smaller weight. 🟣𝐏𝐋𝐀𝐓𝐅𝐎𝐑𝐌𝐒 𝐔𝐍𝐈𝐓𝐄𝐃 Building commercial use cases still requires expensive computing. Meta timed the release with Nvidia's AI Foundry launch. Llama 3.1 can be customised, packaged, and run on Foundry AI from day one. This ecosystem should attract developers. Overnight, Meta and Nvidia have undercut a whole industry by smashing the entry barriers to compete in this space. 🟣𝐁𝐎𝐓𝐓𝐎𝐌 𝐋𝐈𝐍𝐄: 𝐖𝐇𝐄𝐑𝐄 𝐈𝐒 𝐓𝐇𝐄 𝐁𝐎𝐓𝐓𝐎𝐌 𝐋𝐈𝐍𝐄? This is bad news for any company hoping to sell something Meta has just given away for free. The race for the bottom in GenAI pricing has started. The picture gets messier when one considers the financial situation of OpenAI. OpenAI will burn $5 billion this year ($3.5 billion in projected revenues, minus 7 billion compute spend and $1.5 billion staff costs). Which takes me back to the OpenAI valuation headline: ✺How will they justify revenue forecasts❓ ✺Even if o1 lives up to the expectations (i.e. correctly reason logical conclusions from first principle), will that become a commercial blockbuster❓ ✺Where are the viable use cases❓ (Show me the user. I show you the money) Meanwhile, like in Harry Styles's song, the market 𝘸𝘢𝘯𝘵𝘴 𝘮𝘰𝘳𝘦 𝘣𝘦𝘳𝘳𝘪𝘦𝘴; 𝘵𝘩𝘦 𝘮𝘢𝘳𝘬𝘦𝘵 𝘪𝘴 𝘩𝘪𝘨𝘩. TGIF 😎 Happy weekend! i-Expand #commercialization #biotechology #digitalhealth #healthtech #healthcare #uae #venturecapital #entrepreneurship

𝐅𝐨𝐥𝐥𝐨𝐰 𝐭𝐡𝐞 𝐩𝐞𝐨𝐩𝐥𝐞 ► 𝐟𝐨𝐥𝐥𝐨𝐰 𝐭𝐡𝐞 𝐭𝐞𝐜𝐡 ►𝐟𝐨𝐥𝐥𝐨𝐰 𝐭𝐡𝐞 𝐝𝐚𝐭𝐚. There is a shortcut. Join us on Nov 5- 7 for the 7th eHealth Workforce Development Conference 2024 and you will get to learn everything about the GCC’s #healthtech market in one go. 🟣 𝐖𝐇𝐘 𝐘𝐎𝐔 𝐒𝐇𝐎𝐔𝐋𝐃 𝐉𝐎𝐈𝐍 This year’s program will cover all you need to know about data workflows and AI, from cross-border exchanges, health information exchanges, and AI in Healthcare to the fine details of Governance, Privacy and Cybersecurity. That is not all. The who is who of the region will be under one roof: policy-makers, government, providers, industry, and startups. 🟣 𝐅𝐎𝐋𝐋𝐎𝐖 𝐓𝐇𝐄 𝐕𝐀𝐋𝐔𝐄 At the end of the data, there should be value. On Day 2, I will be talking about data monetization as part of the Governance, Privacy and Cybersecurity Summit. This maxim also applies to events. And value is what this conference brings. Don't think it twice: 🔴 JOIN US in Dubai in November! https://lnkd.in/d2aa7Daz ✺ Contact Svetlana Efimova if you want to become a sponsor. See you there? 💃 ✺ Thanks to Osama Elhassan, Ph.D., FIHASI , MWAN Events, and ZIMAM for the opportunity to speak about a topic I am passionate about, and for inviting me to join this year's scientific committee. 🙏 Look forward to meeting you Amr Jamal Ahmed Balkhair Tamara Sunbul, MD, MBA, FHIMSS, CPHIMS, PMP Dr. Meshari F. Alwashmi Rizwan Tufail Shadab Khan Dari Alhuwail, PhD, FAMIA, FIAHSI, Ahmed Alnaji Mazin Gadir PhD MSc BEng PMP Prosci LSSGB EBAS Agile, and many more. #eHWDC24 #GCCeHealth2024 #eHealthConference2024 #MWANEvents 🟣 i-Expand #commercialization #biotechology #healthcare #healthtech #digitalhealth #uae

𝐅𝐎𝐎𝐃, 𝐅𝐑𝐈𝐄𝐍𝐃𝐒 & 𝐁𝐋𝐔𝐄 𝐙𝐎𝐍𝐄𝐒. The confluence of the provinces of Pontevedra, Orense, and Lugo in Galicia has the largest population of ultra-long-lived people in Spain. It will soon become one of the planet's few 'blue zones'. What can we learn from this Atlantic Okinawa? Being Galician, below I will share a few (non-scientific) observations. (Do not try these at home - you may live longer 😊) 🟣 𝐁𝐈𝐎𝐇𝐀𝐂𝐊𝐈𝐍𝐆 -𝐌𝐀𝐃𝐄 𝐈𝐍 𝐆𝐀𝐋𝐈𝐂𝐈𝐀 Much of the #longevity crowd obsesses about diet plans, expensive supplements and gym memberships. Is that the secret? Hardly. Research shows that centenarians from blue zones such as Okinawa, Ikaria or Sardinia follow simple diets, habits, and lifestyles. The food part has always intrigued me. Why? Most blue zones primarily have plant-based diets or consume animal protein in small portions (Japan). Not in #Galicia. 🟣 𝐅𝐎𝐎𝐃 Galicia has the highest consumption of animal protein in Spain. Our answer to Sardinian minestrone is 'Cocido", a stew comprising 70% of meat, including fat and sausages. In 2020, the average Galician consumed 163 eggs, 52kg of meat, 30kg of fish, 90L of milk, 39kg of milk products, 41kg of bread, 18L of oil, 16L of beer, 59kg of vegetables, 110kg of fruits. It is safe to say Galicians eat with gusto. The jury is still out about the Atlantic diet. For now, one reading is that instead of demonizing some foods, we should focus more on quality and balance (20% of cocido is kale and beans). Another is that other epigenetic factors may play a bigger role. 🟣 𝐅𝐑𝐈𝐄𝐍𝐃𝐒 Few longevity studies mention loneliness. A coffee with a friend may be better for your heart than an avocado toast. Loneliness kills. Galician communities are tightly knit. Often, we joke that we have "remote neighbour monitoring". That social capital is a blessing. 🟣 𝐅𝐈𝐄𝐒𝐓𝐀 Life is about joy. Unlike in other nations, older people mingle and party. Thousands of free festivals take place every year. Juaniña, aged 99, was the godmother of the Louro Valley festival. Her biggest regret is that she cannot stay so long on 11cm heels 👠 🟣 𝐑𝐔𝐑𝐀𝐋 𝐅𝐈𝐓𝐍𝐄𝐒𝐒 Not everybody is a dancing queen. Many keep active tending to the garden, fields, or animals. Others walk daily on the beach, in town or to the 300+ community centres. 🟣 𝐆𝐑𝐄𝐄𝐍 & 𝐁𝐋𝐔𝐄 𝐙𝐄𝐍 If zen has a colour, in Galicia it is green (50% of the surface is forest ) and blue ( with 1.2km of coast and 2K rivers). It also has Europe's 2nd highest concentration of thermal baths, excellent air quality and climate. 🟣 𝐇𝐄𝐀𝐋𝐓𝐇 𝐂𝐀𝐑𝐄 Last but not least. Galicians enjoy free quality health services. The lottery postcode is still the most significant determinant of life expectancy. I hope the longevity and ageing #investors don't forget that. Now, I am off for my stroll on the beach. Happy Sunday! i-Expand #commercialization #digitalhealth #healthtech #biotechology #uae

𝐀𝐈 𝐢𝐬 𝐧𝐨𝐭 𝐚𝐛𝐨𝐮𝐭 𝐛𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐚𝐬 𝐮𝐬𝐮𝐚𝐥. If it is, it will fail to deliver its potential. The big opportunity lies in using AI to change the way companies create, deliver, and capture value. For now, it is primarily an automation play. What needs to happen to take us to the next level❓ Here are some thoughts (article + own). 🟣 𝐃𝐈𝐆𝐈𝐓𝐈𝐙𝐄 𝐕𝐒 𝐃𝐈𝐆𝐈𝐓𝐀𝐋𝐈𝐙𝐄 Businesses can use automation (digitation) and augmentation (digitalization) to take them to AI's promised land of fundamental transformation. What's the difference between the two? ▪️Automation takes the work we did yesterday to repeat it at scale, saving costs while increasing efficiencies. ▪️Augmentation enables us to do the work we couldn't do yesterday and achieve new values and outcomes. The combination of automation and augmentation is the real sweet spot for any #business. Those that prioritize automation and cost-cutting strategies are limited to linear growth, at best. It's game-changing digitalization that will reinvent business models and entire industries. 🟣 𝐆𝐞𝐧𝐀𝐈: 𝐖𝐡𝐞𝐫𝐞 𝐢𝐬 𝐲𝐨𝐮𝐫 𝐑𝐎𝐈? Is there ROI in AI? Or rather, where? Businesses are expecting a lot from AI. Expectations don't match the current state of affairs. 𝘞𝘩𝘪𝘭𝘦 𝘢𝘶𝘵𝘰𝘮𝘢𝘵𝘪𝘰𝘯 𝘤𝘢𝘯 𝘤𝘦𝘳𝘵𝘢𝘪𝘯𝘭𝘺 𝘥𝘦𝘭𝘪𝘷𝘦𝘳 𝘲𝘶𝘪𝘤𝘬 𝘸𝘪𝘯𝘴 𝘢𝘯𝘥 𝘤𝘰𝘴𝘵 𝘴𝘢𝘷𝘪𝘯𝘨𝘴, 𝘪𝘵 𝘤𝘢𝘯𝘯𝘰𝘵 𝘢𝘭𝘰𝘯𝘦 𝘥𝘦𝘭𝘪𝘷𝘦𝘳 𝘰𝘯 𝘵𝘩𝘦 𝘧𝘶𝘭𝘭 𝘱𝘰𝘵𝘦𝘯𝘵𝘪𝘢𝘭 𝘰𝘧 𝘈𝘐. 𝘈𝘶𝘵𝘰𝘮𝘢𝘵𝘪𝘰𝘯 𝘴𝘪𝘮𝘱𝘭𝘺 𝘴𝘤𝘢𝘭𝘦𝘴 𝘣𝘶𝘴𝘪𝘯𝘦𝘴𝘴 𝘢𝘴 𝘶𝘴𝘶𝘢𝘭. 𝘛𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺 𝘭𝘦𝘢𝘥𝘦𝘳𝘴 𝘢𝘳𝘦 𝘨𝘰𝘪𝘯𝘨 𝘵𝘰 𝘩𝘢𝘷𝘦 𝘵𝘰 𝘵𝘩𝘪𝘯𝘬 𝘣𝘪𝘨𝘨𝘦𝘳 𝘢𝘯𝘥 𝘥𝘪𝘧𝘧𝘦𝘳𝘦𝘯𝘵𝘭𝘺. So long as we are stuck in old ways of thinking and business models, the only thing #GenAI will disrupt will be the balance sheet for many (liability section). 🟣 𝐀𝐈 𝐇𝐔𝐌𝐀𝐍 Sadly, we cannot digitise our way to transformation. 𝐇𝐮𝐦𝐚𝐧𝐬 𝐦𝐮𝐬𝐭 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦 𝐢𝐧 𝐨𝐫𝐝𝐞𝐫 𝐭𝐨 𝐥𝐞𝐭 𝐀𝐈 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦 𝐨𝐮𝐫 𝐛𝐮𝐬𝐢𝐧𝐞𝐬𝐬𝐞𝐬. The irony? The next wave of AI is human-driven. A good first target will be innovating #business and operational models. A lot of the pillars that will cement this shift are techno-social (strategy & business models, talent, culture). It won't happen overnight. There are good signs: CEOs are now involved in AI. As businesses question how things are done today and explore how AI changes how businesses work, can work, and why, maybe new business and operational models will follow? What is sure: It will take time. Humans love talking more about change, than changing. If only we could automate that... Thanks to Osama Elhassan, Ph.D., FIHASI for highlighting the article. Prof. Georgi Chaltikyan, MD, PhD Lars Dipak Dmitry Dr. Philippe > Our AI Human meme is back :) 🟣 i-Expand #commercialization #biotechology #healthcare #healthtech #digitalhealth #uae

Today Revolut is worth $45 billion and is the most valuable startup in Europe. Here's the pitch deck Revolut used to raise a £1.5 million seed round 👇😳 It's a masterclass on how to make a winning pitch deck: - Nails the problem: Revolut pinpointed the pain we all felt with high banking fees and slow transactions 💸 - Offers a game-changing solution: a digital bank with fee-free global spending and instant access? Yes, please! 🎯 - Seizes a massive market: tapping into the huge financial services market with a product that scales fast 🚀 This is a perfect blueprint for how to sell your vision and win VCs effortlessly. Pure brilliance 👏 P.S. check out 🔔linas.substack.com🔔, it's the only newsletter you need for all things when Finance meets Technology. For founders, builders, and leaders.

1, 2, 3, 𝐒𝐭𝐚𝐫𝐭𝐀𝐃. 💃 Today, we launch Week 3 of the HealthX accelerator programme. Powered by startAD and the Department of Health Abu Dhabi, it is a privilege to be part of the first HealthX’s training core team under the baton of Dragonfly Andrew.   Are you a #healthtech startup? Interested in coming to the #UAE?  If so, read on. 🟣 ABOUT HEALTHX HealthX is a startup program developed as a collaborative initiative between the Department of Health and startAD.  The programme is an incredible opportunity for companies to tap into the UAE market and offers, amongst others: ▪️Six weeks of training about the UAE market, including a networking trip to Abu Dhabi. ▪️Potential to partner with renowned hospital chains as customers and pitch at GITEX, the largest tech event in the region. ▪️Licensing support and regulatory sandbox access from the Department of Health. The first cohort of HealthX focuses on AI and GenAI. 🟣 MEET COHORT I Launched during the Olympics, HealthX already has ten gold medals: the companies selected for the first cohort. 🥇Congratulations to Autonomize AI, Healee, Health Exam, Medwise AI, MayaMD.AI, Prism, Sully.ai, TheDecisionLabs, Xpertree and KeyReply. Your involvement and enthusiasm so far has been incredible. 🟣 SAD YOU MISSED IT?    Rumour has it that StartAD will announce a new cohort in the next few weeks.  Get in touch to be the first one to find out, especially if you work in the #genomics #precisionmedicine area. Don’t let this opportunity pass you: we can help you propel your entry into the UAE! Now, let Week 3 roll on 🏁 Thanks to Adnan Dekedek, Dominique Jade Chatfield, Rami Jundi and the overall StartAD/NYU Abu Dhabi for this opportunity. Working with you, our esteemed partners and the extended team is a pleasure. Andrew B. Jeremy Henrichs Jonas Duss Howard Gough, Mark Adams and so many more (on picture and not). #startAD #NYUAbuDhabi #Tamkeen #AHealthierAbuDhabi #HealthX #startups #healthcare #AI #ArtificialIntelligence #innovation #technology 🟣 i-Expand #commercialization #biotechology #healthtech #digitalhealth #entrepreneurship MedTech World Dylan Attard MD, MRCSI,

𝐇𝐞𝐚𝐥𝐭𝐡 𝐓𝐞𝐜𝐡 𝐬𝐭𝐚𝐫𝐭𝐮𝐩𝐬 🔺: Do you have an innovative solution that could significantly impact global health? Is your vision to enter the Saudi market? Then, Vision NextGen is the right platform for you. 🟣ABOUT THE COMPETITION Vision NextGen (previously known as Innov8) is organizing a competition that will bring together visionaries, #entrepreneurs, and change-makers to address some of the world's most pressing health challenges. The competition is part of the Global Health Exhibition - ملتقى الصحة العالمي -KSA's flagship healthcare event- which will take place in Riyadh on October 21-23. 🟣 WHY YOU SHOULDN'T MISS IT This conference will shed light on ground-breaking innovations that could align with Saudi Arabia's Vision 2030. The movers and shakers will be there. 👀 Will that light point to you❓ If so, what will you show us❓ Join us in person on October 21 – 23 and let's find out! 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐝𝐞𝐚𝐝𝐥𝐢𝐧𝐞 – 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 9 2024 (link in comments) PS: As part of the jury, a slide on #business viability will do wonders. 😎 🟣 See you there? 💃 Thanks to Felicia Madsen Summaya Badbess Mohamad Sabri and the Informa and Tahaluf team for this great opportunity. 🟣 i-Expand #commercialization #biotechology #healthcare #healthtech #digitalhealth #startups

Interested in the GCC #healthtech market ❓ Keen to meet the movers and shakers ❓ Not sure which event to attend ❓ Look no more: The 7th GCC eHealth Workforce Development Conference 2024 is your go-to event. 🔶 Just like every year, ZIMAM has gathered a strategic Committee for this year's conference. Our goal? To raise the bar once again by bringing to you the most strategic #ehealth conference! 🔶 Interested in speaking and sponsorship opportunities? Reach out to Svetlana Efimova or DM me. 🔴JOIN us Nov 5-7, 2024 in #Dubai #UAE. https://lnkd.in/d2aa7Daz See you all there! PS: Thanks to Osama Elhassan, Ph.D., FIHASI MWAN Events and ZIMAM for the privilege and honour to join such esteemed company. #eHWDC2024 #GCCeHealth #digitalhealth #healthcare Osama Elhassan, Ph.D., FIHASI Amr Jamal Ahmed Balkhair Tamara Sunbul, MD, MBA, FHIMSS, CPHIMS, PMP Suliman Omran Alomran Riyad Alshammari, PhD Khalid Alyafei Shadab Khan Dr. Meshari F. Alwashmi Badar Awladthani Rizwan Tufail Ahmed Alnaji Dr. Mohammed Alhamali Dari Alhuwail, PhD, FAMIA, FIAHSI Abdulrahman Alqahtani Yazid Alazwari MWAN Events i-Expand

Did Llama just eat OpenAI's commercial playbook? 🦙 Last week, Meta dropped a bomb on the GenAI industry by offering more than OpenAI does and for free. Releasing open-source models is not new. Why is this time different? Why it matters? 🟣 𝐌𝐄𝐄𝐓 𝐓𝐇𝐄 𝐍𝐄𝐖 𝐋𝐋𝐌 𝐋𝐋𝐀𝐌𝐀 Meta is making its flagship model, Llama 3.1. 405B, available to anyone. This version can do pretty much anything that OpenAI, Gemini or Anthropic are capable of and -reportedly- at a similar level of quality. Further, companies may do so at a fraction of the cost. GPT-4, Gemini, and Claude are 2-4x the size of Llama 3.1 405B. While Llama might need more training, executing inference might be cheaper because of its smaller weight. Even so, building commercial use cases will require expensive computing capacity, which takes us to another game-changer announcement. 🟣 𝐏𝐋𝐀𝐓𝐅𝐎𝐑𝐌𝐒 𝐔𝐍𝐈𝐓𝐄𝐃 Meta timed the release with Nvidia's AI Foundry launch. The first open-source flagship model can be customised, packaged, and run on Foundry AI from day one. This ecosystem should attract developers. Meta has undercut the whole industry. Nvidia has sealed it. Other #platform plays followed (AWS, Databricks, and Groq support the model). Overnight, Meta and Nvidia have smashed the entry barriers to compete in this space. The biggest risk of big tech is their penchant for price dumping. They can afford it -unlike most #startups. 🟣𝐖𝐇𝐀𝐓 𝐈𝐓 𝐌𝐄𝐀𝐍𝐒 𝐅𝐎𝐑 𝐀𝐈 𝐒𝐓𝐀𝐑𝐓𝐔𝐏𝐒 This is bad news for any company hoping to sell something Meta will give for free. The picture gets messier when one considers the financial situation of the top two leading startups. OpenAI will burn $5bn this year ($3.5bn sales, minus 7bn compute spend and $1.5bn staff costs). Anthropic expects to burn around $2.7bn. Financing rounds should be in order. How will they justify current revenue forecasts, given that Meta will offer the same cheaper or for free?❓ Should developers bet on proprietary systems❓ 🟣 𝐁𝐈𝐆𝐆𝐄𝐑 𝐏𝐈𝐂𝐓𝐔𝐑𝐄- 𝐒𝐇𝐎𝐖 𝐌𝐄 𝐓𝐇𝐄 𝐔𝐒𝐄 𝐂𝐀𝐒𝐄 The race for the bottom in #GenAI pricing has started. The overall #AI numbers show that investments keep increasing while revenues don't. Will the estimated $1T in AI capex in the coming years pay off? If not, what does that mean for businesses and investors? FOMO is still going strong, yet the bear market ears are sticking out. It doesn't mean that AI will not be transformative. It shows the eternal mismatch between expectations and market realities, courtesy of Mr. hype. Few know how to build AI solutions, and even fewer know how to use them. Who drives adoption❓ 𝑺𝒉𝒐𝒘 𝒎𝒆 𝒕𝒉𝒆 𝒖𝒔𝒆𝒓. 𝑰 𝒔𝒉𝒐𝒘 𝒚𝒐𝒖 𝒕𝒉𝒆 𝒎𝒐𝒏𝒆𝒚. But first, let's build viable use cases. (that is, unless you prefer to be a drama llama). Thanks to Richard Windsor, Jeffrey Funk for data from their posts. 🟣 i-Expand #commercialization #biotechology #healthcare #healthtech #digitalhealth #business #uae #ai